Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF.
Eur Heart J Cardiovasc Pharmacother · 2025-Nov-04 · PMID 40839760
CV Death or First HF Hospitalization
Figure 4 Cumulative incidence of the composite outcome according to baseline EuroQol Five-dimension Three-level (EQ-5D-3L) Questionnaire. ( A ) ‘Mobility’ domain; ( B ) ‘self-care’ domain; ( C ) ‘usual activities’ domain; ( D ) ‘pain/discomfort’ domain; ( E ) ‘anxiety/depression’ domain; ( F ) Level Sum Score (LSS) category divided by tertile; ( G ) Visual Analog Scale (VAS) category divided by tertile. The patients reported ‘Some problem’ and ‘Extreme problem’ were combined into one group due to a small number in the worst category of ‘mobility’ domain ( n = 27) and ‘self-care’ domain ( n = 73). CV, cardiovascular; HF, heart failure.
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | quality_warning | 待验证 | 2 | 2026-07-23T17:57:56+00:00 |